The results obtained in the present study showed that the mean concentration of both TIMP-1 and TIMP-2 in the blood plasma of patients with scleroderma was higher, compared to the concentrations of these inhibitors in the blood plasma of healthy individuals. The gene discussed is TIMP1; the disease is scleroderma.